logo
Login
Open Account
Open Demat

Sector: Pharmaceuticals & Biotechnology

|

Mid Cap

Jubilant Pharmova Share Price

Jubilant Pharmova Ltd.

₹1,011

-3.20(-0.32%)

Invest in JUBLPHARMA with up to 2.50x margin.

Trade with MTF
21st May 2026 | 3:28 PM
NSE : JUBLPHARMA
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Jubilant Pharmova Performance

Price Movement

₹1011.00

₹999.30

₹1023.30

↘ Today's Low↗ Today's High

1 Year Performance

₹1011.00

₹786.05

₹1248.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,023.30
Low₹999.30
Open at₹1,022.00
Prev Close₹1,014.20
Volumes90.79 K
Avg Price₹1,008.27
Lower Circuit₹811.40
Upper Circuit₹1,217.00

Historical Performance

3M High₹1,031.70
3M Low₹786.05
1 Yr High₹1,248.00
1 Yr Low₹786.05
3 Yr High₹1,309.90
3 Yr Low₹318.75
5 Yr High₹1,309.90
5 Yr Low₹268.90

Jubilant Pharmova Fundamentals

Market Cap
High in industry
16,154.30 Cr.
PE Ratio (TTM)
Above industry Median
37.30
Dividend Yield
Below industry Median
0.50
Net Profit TTM
31% decr over last year
432.70
Net Profit Growth
31% decr over last year
432.70
PEG Ratio
Negative PEG TTM
-1.20
ROE
851.1% incr over last year
13.41
Operating Revenue TTM
7,918.40
Operating Revenue Growth
12.1% incr over last year
Book Value
Below industry Median
2.40
MFI
MFI Overbought
77.55
RSI
RSI is mid-range
69.19
EPS (TTM)
52.99
Debt to Equity
0.39
Face Value
1
Operating Profit Margin Qtr.
16.10
Operating Profit Qtr.
289.50
Net Profit Qtr.
55.90
Operating Revenue Qtr.
2,122.50
PB Ratio
2.40

Jubilant Pharmova Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue67.3066.4059.50217.30196
Operating Expense55.1054.6049.20191.30185
Operating Profit12.2011.8010.302611
Depreciation1.601.601.5013.4013.30
Interest0.902.50377.40
Tax3.5056.502.409.903.40
Net Profit6.60-6.405.8013.605.30

Jubilant Pharmova Technicals

Jubilant Pharmova Ltd. EMA & SMA

₹1011.00

0.05 (0.00%)

↗ Bullish Moving Average

15

↘ Bearish Moving Average

1

Day EMA5 ₹1002.3
Day EMA10 ₹990.3
Day EMA12 ₹985.2
Day EMA20 ₹966.4
Day EMA26 ₹955.2
Day EMA50 ₹935.6
Day EMA100 ₹949.8
Day EMA200 ₹981.2

Jubilant Pharmova Support and Resistance

Resistance

First Resistance₹1027.63
Second Resistance₹1044.32
Third Resistance₹1058.63

Support

First Support₹996.63
Second Support₹982.32
Third Support₹965.63

Technical Indicators

Day RSI69.19
Day MFI77.55
Day ADX28.31
Day Commodity Channel Index108.10
William-18.01
Day MACD30.08
Day MACD Signal Line27.65
Day ATR30.18
Day ROC125-10.22
Day ROC2110.98

Jubilant Pharmova Shareholding Pattern

Held ByDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoter50.750.747.747.747.747.7
FII1717.217.416.61615.9
DII77.19.510.511.211.6
Public24.824.524.824.624.624.2

Jubilant Pharmova Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day1.76 L2.79 L63.18%
Week75.65 K1.37 L55.15%
1 Month66.95 K1.25 L53.68%
6 Month80.67 K1.52 L52.91%

Jubilant Pharmova SWOT Analysis

Strengths20
Weakness4
Opportunity6
Threats0

Benjamin Graham Value Screen

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Results Screener: Stocks with upcoming results which are seeing positive shifts in share price

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Companies with reducing Debt

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

RSI indicating price strength

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Jubilant Pharmova Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
25 Jul, 20255FINAL25 Jul, 2025Equity Share
02 Aug, 20245FINAL02 Aug, 2024Equity Share
10 Aug, 20235FINAL10 Aug, 2023Equity Share
11 Aug, 20225FINAL12 Aug, 2022Equity Share
05 Aug, 20215FINAL06 Aug, 2021Equity Share
09 Mar, 20205INTERIM11 Mar, 2020Equity Share
12 Sep, 20194.5FINALEquity Share
12 Sep, 20183FINALEquity Share
16 Aug, 20173FINALEquity Share
18 Aug, 20163FINALEquity Share

Jubilant Pharmova Stock Comparison

Financials
Corona Remedies Ltd.
Sudeep Pharma Ltd.
Rubicon Research Ltd.
Akums Drugs & Pharmaceuticals Ltd.
Innova Captab Ltd.
Concord Biotech Ltd.
Price (₹)₹1,720₹665₹967.50₹523.45₹870.50₹1,121
% Change-0.68%2.29%-1.88%1.65%-1.10%0.45%
Revenue TTM (₹ Cr)₹1,403.18-₹1,598.19₹4,359.02₹1,630.02₹1,158.69
Net Profit TTM (₹ Cr)₹185.12-₹206.20₹255.19₹140.92₹312.50
PE TTM57.20-78.9031.8035.7037.40
1 Year Return63.079.63103.31-6.77-4.7-26.82
ROCE31.5434.7834.7611.4015.2726.82

FAQ's on JUBLPHARMA

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy